In addition, some studies have indicated that the regulation of TGF-β expression by extracellular vesicle-mediated ROR transfer regulates the tolerance of CD133+ liver cancer stem cells to chemotherapeutic drugs [15]. Here, TGFB1 is linked to liver cancer.